Operational tolerance in liver transplantation: Shall we predict or promote?

Liver Transplantation

Volumn 19, Issue 9, 2013, Pages 933-936

  McCaughan, Geoffrey W ^a,b   Bowen, David G ^a,b   Bertolino, Patrick ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HEPCIDIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS; THYMOCYTE ANTIBODY;

CD8+ T LYMPHOCYTE; CHIMERA; CORTICOSTEROID THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENTION TO TREAT ANALYSIS; KIDNEY ALLOGRAFT; LEUKOCYTE; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOCYTE; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFORMATION TEST; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; TRANSPLANTATION TOLERANCE;

EID: 84883238404     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23719     Document Type: Review

References (32)

1. Benseler V, McCaughan GW, Schlitt HJ, Bishop GA, Bowen DG, Bertolino P,. The liver: a special case in transplantation tolerance. Semin Liver Dis 2007; 27: 194-213.
2. Kamada N,. The immunology of experimental liver transplantation in the rat. Immunology 1985; 55: 369-389.
3. Alex Bishop G, Bertolino PD, Bowen DG, McCaughan GW,. Tolerance in liver transplantation. Best Pract Res Clin Gastroenterol 2012; 26: 73-84.
4. Alexander SI, Smith N, Hu M, Verran D, Shun A, Dorney S, et al. Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl Med 2008; 358: 369-374.
5. McCaughan GW,. Withdrawal of immunosuppression in liver transplant recipients: is this as good as it gets? Liver Transpl 2002; 8: 408-410.
6. Porrett P, Shaked A,. The failure of immunosuppression withdrawal: patient benefit is not detectable, inducible, or reproducible. Liver Transpl 2011; 17 (suppl 3): S66-S68.
7. Sánchez-Fueyo A,. Hot-topic debate on tolerance: immunosuppression withdrawal. Liver Transpl 2011; S69-S73.
8. Banff Working Group on Liver Allograft Pathology. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. Liver Transpl 2012; 18: 1154-1170.
9. Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA 2012; 307: 283-293.
10. Levitsky J,. Immunosuppression withdrawal following liver transplantation: the older, the wiser.but maybe too late. Hepatology; doi: 10.1002/hep.26576.
11. Benítez C, Londoño MC, Miquel R, Manzia TM, Abraldes JG, Lozano JJ, et al. Prospective multi-center clinical trial of immunosuppressive drug withdrawal in stable liver transplant recipients. Hepatology; doi: 10.1002/hep.26426.
12. Orlando G, Soker S, Wood K,. Operational tolerance after liver transplantation. J Hepatol 2009; 50: 1247-1257.
13. Martínez-Llordella M, Puig-Pey I, Orlando G, Ramoni M, Tisone G, Rimola A, et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007; 7: 309-319.
14. Martínez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, Lerut J, et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008; 118: 2845-2857.
15. Bohne F, Martínez-Llordella M, Lozano JJ, Miquel R, Benítez C, Londoño MC, et al. Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest 2012; 122: 368-382.
16. Li L, Wozniak LJ, Rodder S, Heish S, Talisetti A, Wang Q, et al. A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation. Am J Transplant 2012; 12: 1218-1228.
17. de la Garza RG, Sarobe P, Merino J, Lasarte JJ, D'Avola D, Belsue V, et al. Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance. Liver Transpl 2013; 19: 937-944.
18. Yoshitomi M, Koshiba T, Haga H, Li Y, Zhao X, Cheng D, et al. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation 2009; 87: 606-614.
19. Pons JA, Revilla-Nuin B, Baroja-Mazo A, Ramírez P, Martínez-Alarcõn L, Sánchez-Bueno F, et al. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Transplantation 2008; 86: 1370-1378.
20. + regulatory T cells. Am J Transplant 2008; 8: 1639-1651.
21. + regulatory cells. Liver Transpl 2010; 16: 147-154.
22. Benítez CE, Puig-Pey I, Lõpez M, Martínez-Llordella M, Lozano JJ, Bohne F, et al. ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation. Am J Transplant 2010; 10: 2296-2304.
23. Sriwatanawongsa V, Davies HS, Calne RY,. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats. Nat Med 1995; 1: 428-432.
24. Sun J, McCaughan GW, Gallagher ND, Sheil AG, Bishop GA,. Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 1995; 60: 233-236.
25. Sun J, Sheil AG, Wang C, Wang L, Rokahr K, Sharland A, et al. Tolerance to rat liver allografts: IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes. Transplantation 1996; 62: 1725-1730.
26. Kamada N, Shinomiya T,. Clonal deletion as the mechanism of abrogation of immunological memory following liver grafting in rats. Immunology 1985; 55: 85-90.
27. Qian S, Lu L, Fu F, Li Y, Li W, Starzl TE, et al. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 1997; 158: 4654-4661.
28. Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, Bertolino P,. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 2004; 114: 701-712.
29. Benseler V, Warren A, Vo M, Holz LE, Tay SS, Le Couteur DG, et al. Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc Natl Acad Sci U S A 2011; 108: 16735-16740.
30. Holz LE, Benseler V, Bowen DG, Bouillet P, Strasser A, O'Reilly L, et al. Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology 2008; 135: 989-997.
31. Wang C, Sun J, Sheil AG, McCaughan GW, Bishop GA,. A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation 2001; 72: 44-51.
32. Bishop GA, Ierino FL, Sharland AF, Hall BM, Alexander SI, Sandrin MS, et al. Approaching the promise of operational tolerance in clinical transplantation. Transplantation 2011; 91: 1065-1074.